More recent clinical data from lung [10], breast [11], [12], pancreatic [13], hepatocellular [14], and urinary bladder cancer [15] as well as melanoma [16] provided first evidence for a Foxp3 expression also in tumor cells. The gene discussed is FOXP3; the disease is urinary bladder cancer.